Bruker Corporation (BRKR)
BRKR Price and Sentiment
BRKR Latest news
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2021 financial results on Monday, November 1, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q3 2021 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide pre
The heavy selling pressure might have exhausted for Bruker (BRKR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research2021-10-01 07:00
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that it has received orders for two 1.1 GHz NMR Avance Neo systems from U.S. academic institutions funded by the National Science Foundation (NSF). NSF awarded the funds to establish the Network for Advanced NMR (NAN) linking three institutions including the University of Connecticut School of Medicine, the University of Georgia and University of Wisconsin–Madison. NAN is a novel consortium with the goal to est
Bruker posted better-than-expected second quarter results, as the company is seeing a broad recovery across its academic, applied, clinical, and industrial end-markets. Project Accelerate 2.0 is the next iteration of an already-successful program to refocus the company's core technologies and capabilities on growth markets in life sciences and diagnostics.
The stock price of Bruker Corporation, a scientific instruments manufacturer, primarily for molecular and materials research, has seen a rise of around 12% over the last twenty-one trading days, and it is up a solid 123% over the last twelve-month period. The rally in BRKR stock over the recent.
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
JoAnne Feeney, Advisors Capital Management, joins Fast Money Special Edition to discuss profitable stocks that are lesser known.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, and Falko Busse, President of the Bruker BioSpin Group, will participate in an analyst moderated question and answer session on behalf of the Company on Friday, September 10, 2021 at 9:20 AM Eastern Time. A live audio webcast of the question and answer session will be
Investors are optimistic about Bruker (BRKR) on solid BSI Nano Group growth potential and raised 2021 financial guidance.